• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Coliseum Nominates Slate of Highly Qualified and Engaged Director Candidates for Election at Purple Innovation 2023 Annual Meeting

    2/13/23 8:30:00 AM ET
    $BIOS
    $LAZY
    $LOGI
    $MODV
    Blank Checks
    Finance
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary
    Get the next $BIOS alert in real time by email

    Will Support Re-Election of CEO Rob DeMartini to Board

    No Longer Pursuing September 2022 Take Private Proposal

    Shareholders Deserve Nimbler, More Engaged Board with Heightened Sense of Urgency and Bias for Action to Help Management Navigate Challenges Ahead

    Coliseum Capital Partners, L.P. ("Coliseum"), the largest stockholder of Purple Innovation, Inc. (NASDAQ:PRPL) ("Purple"), announced today that it has nominated five candidates for election to Purple's seven member Board of Directors at the company's 2023 Annual Meeting of Stockholders, including Adam Gray, a current Purple director and Managing Partner and Co-Founder of Coliseum Capital Management, LLC.

    Coliseum also announced that it intends to support the re-election of Purple's Chief Executive Officer, Rob DeMartini, and not oppose the election of one other nominee proposed by Purple management after review of their slate. If Mr. DeMartini is not re-elected, Coliseum intends to recommend that he be immediately appointed a director.

    Coliseum also confirmed that it is no longer pursuing its September 2022 proposal to acquire the remaining shares not owned by Coliseum. Coliseum committed that if it does make a similar proposal in the future, it will be conditioned on the same terms as the September 2022 proposal: it must be approved by a special committee of Purple's board and by the holders of a majority of the stock not then owned by Coliseum.

    Coliseum issued the following letter to Purple stockholders which includes background information on Coliseum's nominees:

    Dear fellow stockholders of Purple Innovation, Inc. ("Purple" or the "Company"),

    Five Years After its De-SPAC Merger, Purple's Common Stock Now Trades 54% Below its IPO Price, and 89% Below its All-Time High1

    While we (Coliseum Capital Partners, L.P., together with our affiliates, "Coliseum") are enthusiastic about the Company's longer-term prospects, and strongly supportive of its existing management team, we also recognize that the road ahead – particularly over the next 12-24 months – will be neither straight nor smooth. Purple needs, and shareholders deserve, a far nimbler board with a heightened sense of urgency to help management navigate these challenges and halt further deterioration of shareholder value. As the Company's largest shareholder, our interests are squarely aligned with yours.

    To be clear, we believe that the current non-executive directors are good people with good intentions. Nevertheless, we believe that after five years of disappointing returns it is time for shareholders to demand change. Absent significant change, we no longer have confidence in this board's ability to help steward the Company through current headwinds, and to unlock the value creation that we believe is achievable. Accordingly, and in the absence of agreement with the Company for an overhaul in the non-executive composition of its board, we have decided to pursue this public nomination process. Further, given our conviction that such an overhaul is necessary, we are funding this initiative on behalf of all shareholders without a customary request that the Company reimburse such costs if our slate is elected.

    As you will see below, our proposed directors are accomplished, dynamic business leaders: value creators with deep and relevant experience navigating headwinds, transformation, and growth. We believe, and hope you will agree, that their skillset, fresh perspective, and energized engagement will prove critical for the benefit of all shareholders.

    Our Interests are Squarely Aligned

    We have been strong and consistent supporters of the Company since its February 2018 de-SPAC merger, funding nearly $110 million (about half) of the equity capital Purple has raised to enable the Company's journey to date. With ownership today of nearly 47 million shares of Purple's common stock (approximately 45% of the outstanding common stock), Coliseum is the Company's largest stockholder; our interests are deeply, squarely aligned with yours.

    In contrast, based on our review of public filings, the other five non-executive directors, taken as a whole, have written checks to acquire only approximately 57,000 shares and today hold approximately 323,000 shares (approximately 0.3% of the outstanding common stock).2

    No Longer Pursuing Going-Private; Restating Commitment to Stockholder-Friendly Conditions

    As you may know, in September 2022, Coliseum proposed to take Purple private in a transaction that offered Purple stockholders a 56% premium over Purple's closing stock price the day before our proposal. About four months later, a special committee of Purple's independent directors formally rejected our proposal. While we were disappointed by what we viewed as the special committee's lack of engagement, we respect the special committee's decision. We confirm today that we are no longer pursuing a going-private transaction with Purple.

    Importantly, when we made our proposal in 2022, we insisted that any transaction would occur only if it was supported by an independent, special committee of Purple's board and by holders of a majority of the stock not held by Coliseum. We further confirm today that, while we have no current plan to pursue a going-private transaction with Purple, if we proposed any such transaction in the future, we would commit to those same stockholder-friendly conditions.

    The Road Ahead Will Continue to be Difficult… Requiring a Nimbler, More Engaged Board with Heightened Sense of Urgency and Bias for Action

    Our view -- that Purple has a terrific opportunity to create and unlock substantial value for its shareholders -- has been bolstered by the strength of Rob DeMartini, by the team he is building, and by the clarity with which Rob has outlined and actioned key strategic and operating priorities. That said, Purple faces a tough macroeconomic environment, strong industry headwinds, and aggressive competitive activity. We believe the action we are taking today to refresh the board will lead to a nimbler, more engaged board of directors, critical to support management and to protect shareholders from the elevated downside risk evident at this time.

    Proposed Slate of Director Nominees Highly Qualified to Deliver the Change Shareholders Deserve

    In addition to supporting the reelection of current director and Coliseum co-founder Adam Gray, we are nominating for election to Purple's board four new directors, all of whom are known by us largely through their service as executives and/or board members at other companies in which Coliseum is or was invested where they helped navigate headwinds, transformation and growth, ultimately protecting and driving substantial value for shareholders.

    We hope you will agree that these five director nominees, each of whom is accomplished in her/his own right and shares our commitment to work tirelessly on behalf of all Purple shareholders, represent the change we deserve.

    To be clear, Coliseum is not proposing to change the entire board of Purple because we believe Purple and its stockholders will benefit from the continued service on the board of Purple's Chief Executive Officer, Rob DeMartini, and of Mr. Gray. In fact, if Mr. DeMartini is not reelected to the Purple board, Coliseum intends to recommend that he be immediately appointed to that role.

    Nevertheless, we believe that after five years of disappointing shareholder returns – with the Company's common stock trading 54% below its IPO price and at levels 89% below its all-time high touched February 20213 – the board requires major refreshment. Indeed, three of the existing directors are holdovers who were chosen almost eight years ago to be directors of a blank-check SPAC entity that had no operations. New skillsets and experience are required to oversee Purple's public company operations.

    Below is a brief biography of each of our nominees:

    S. Hoby Darling. Hoby has held several executive roles at Logitech International (NASDAQ:LOGI), including most recently as head of its sports and human performance advisory business. He was previously CEO of Skull Candy (NASDAQ:SKUL), a leading consumer audio and technology company. Prior to joining Skull Candy, Hoby held several roles at Nike, Inc. (NYSE:NKE), including as Global GM of Nike+ Digital Sport and as Head of Strategy and Planning for Nike Affiliates. Prior to Nike, Hoby served as SVP, Strategic Development and General Counsel, at Volcom, Inc. (NASDAQ:VLCM), a leading manufacturer and marketer of consumer lifestyle products. Hoby began his career as a corporate attorney at the global law firm of Latham & Watkins. While we have not worked directly with Hoby, we believe that his multi-channel consumer brand leadership credentials, particularly involving innovative technology and its ability to improve lifestyle outcomes, and his sense of urgency and drive for performance/accountability will be valuable additions to Purple's boardroom.

    Erika Serow. Erika is the Chief Marketing Officer of Bain & Company ("Bain"), responsible for Bain's global marketing and communication teams, and a member of Bain's Global Operating Council (Executive Leadership Team), where she serves on the Investment and Risk committees. Prior to this role, Erika was the Global President and US CEO for Sweaty Betty, a premium athletic apparel company. Erika began her career with a 20-year stint as a consultant at Bain, where she ultimately led the firm's Retail practice in the Americas. We have seen, firsthand, the value Erika has brought to Lazydays Holdings (NASDAQ:LAZY) through her role on its Board of Directors since March of 2018, including on the Nominating and Governance Committee and Compensation Committee. We believe that Erika's deep knowledge and experience helping marquee consumer brands navigate strategy and execution across various stages of transformation, including through each of digital, wholesale, and retail channels, will be of significant value to the Board.

    R. Carter Pate. We have seen Carter add (and protect) enormous value in a number of roles, including as Chairman of BioScrip (NASDAQ:BIOS) and as a board member of its successor company, OptionCare Health (NASDAQ:OPCH), Chairman of Red Lion Hotels (NASDAQ:RLH), and other public company board roles. We also appreciate his tireless work and substantive contributions during his service as the former CEO of ModivCare, Inc (NASDAQ:MODV). Carter's drive and determination, and his experience as part of the Global Leadership Team and in leading the restructuring/performance-improvement practice at PricewaterhouseCoopers, will be terrific complements to this refreshed Purple's board.

    Robert DeVincenzi. We have had the pleasure of working with Bob over many years. Bob currently serves as Chairman of the Board of Universal Technical Institute (NYSE:UTI), and as the Lead Independent Director of Lazydays Holdings Inc. (NASDAQ:LAZY), where he also served as Interim CEO. Prior, Bob served as President and CEO and then as a board member of Redflex Holding Limited; and held a number of other senior executive positions at a variety of technology and services companies, spanning sales, marketing, strategy and more. We believe that Bob's long history of navigating change and creating shareholder value with an operator's keen sense of urgency, bias for action and drive for accountability; his deep knowledge of technology, manufacturing, and supply chain; and his extensive public company board experience will be invaluable within the Purple boardroom.

    Adam Gray. Adam Gray is a managing partner and co-founder of Coliseum, a private firm that makes long-term investments. In this role, he has served on the boards of directors of a number of public and private companies. Prior to launching Coliseum in 2005, Adam worked for nearly 20 years with and on behalf of top-tier private equity firms. We believe that Adam's demonstrated track record of value creation through operating, turnaround and restructuring roles, combined with his private and public equity investing credentials, will help enable Purple's future success.

    * * *

    We are optimistic that, with the significant changes in Purple's governance we are proposing, Purple will be much better positioned to continue its journey as a publicly traded company. As Purple's largest stockholder, with approximately 45% of the outstanding common stock, Coliseum is squarely aligned with you in seeking long-term success for Purple. We believe that success is attainable, but it is not assured; without substantial change, we lack confidence in the current board's ability to help navigate these challenging times.

    We are asking stockholders to think carefully about their options at the upcoming meeting.

    Vote with the Company's largest stockholder and for a reinvigorated slate that is committed to steering the Company towards long-term success.

    Or vote to retain the status quo, despite our lack of confidence in the current board, and risk further destruction of shareholder value.

    We look forward to introducing our slate of nominees to you, and to our continued engagement.

    CERTAIN INFORMATION CONCERNING THE PARTICIPANTS

    Coliseum Capital Partners, L.P. ("CCP"), together with the other participants named herein (collectively, "Coliseum"), intends to file a proxy statement and accompanying universal proxy card with the Securities and Exchange Commission ("SEC") to be used to solicit votes for the election of its slate of nominees for election to the Board of Directors (the "Board") of Purple Innovation, Inc. (the "Company") at the 2023 Annual Meeting of Stockholders of the Company to be held as may be determined by the Board (including any other meeting of stockholders held in lieu thereof, and any adjournments, postponements, reschedulings or continuations thereof, the "Annual Meeting").

    COLISEUM STRONGLY ADVISES ALL STOCKHOLDERS OF THE COMPANY TO READ THE PROXY STATEMENT AND OTHER PROXY MATERIALS, INCLUDING THE PROXY CARD, AS THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. SUCH PROXY MATERIALS WILL BE AVAILABLE AT NO CHARGE ON THE SEC'S WEBSITE AT HTTP://WWW.SEC.GOV. IN ADDITION, THE PARTICIPANTS IN THIS PROXY SOLICITATION WILL PROVIDE COPIES OF THE PROXY STATEMENT WITHOUT CHARGE, WHEN AVAILABLE, UPON REQUEST. REQUESTS FOR COPIES SHOULD BE DIRECTED TO THE PARTICIPANTS' PROXY SOLICITOR, INNISFREE M&A INCORPORATED, AT ITS TOLL-FREE NUMBER 1 888 750 5834 OR VIA EMAIL AT [email protected].

    The participants in the proxy solicitation are anticipated to be Coliseum Capital Partners, L.P., Coliseum Capital, LLC ("Coliseum Capital"), Coliseum Capital Management, LLC ("CCM"), Seth "Hoby" Darling, Robert DeVincenzi, Adam Gray, R. Carter Pate, Erika Serow, Christopher Shackelton, Christopher Murphy and Chivonne Cassar.

    Information regarding the persons who may, under the rules of the SEC, be deemed participants in the solicitation of proxies in connection with the election of Coliseum's nominees as directors of the Company, including a description of their direct or indirect interests, by security holdings or otherwise, will be set forth in the proxy statement and other proxy materials when they are filed with the SEC.

    As of the date hereof, CCP beneficially owns 30,341,629 shares of Class A common stock, par value of $0.0001 per share, of the Company (the "Class A Stock"). As of the date hereof, Coliseum Capital beneficially owns 33,475,078 shares of Class A Stock. As of the date hereof, CCM beneficially owns 40,854,130 shares of Class A Stock. As of the date hereof, Adam Gray beneficially owns 40,854,130 shares of Class A Stock. As of the date hereof, none of Seth "Hoby" Darling, Robert DeVincenzi, R. Carter Pate, Erika Serow, Christopher Murphy or Chivonne Cassar beneficially owns any securities of the Company. As of the date hereof, Christopher Shackelton beneficially owns 40,854,130 shares of Class A Stock.

    ____________________________

    1 Purple common stock closed at $4.56 on February 10, 2023 and $40.05 per share on February 19, 2021. Purple's IPO price in February 2019 was $10 per share.

    2 Excludes shares granted as compensation for Board service or received as a result of cashless exercise of warrants.

    3 Purple common stock closed at $4.56 on February 10, 2023 and $40.05 per share on February 19, 2021. Purple's IPO price in February 2019 was $10 per share

    View source version on businesswire.com: https://www.businesswire.com/news/home/20230213005197/en/

    Get the next $BIOS alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BIOS
    $LAZY
    $LOGI
    $MODV

    CompanyDatePrice TargetRatingAnalyst
    Logitech International S.A.
    $LOGI
    8/5/2025$109.00Neutral → Outperform
    BNP Paribas Exane
    Nike Inc.
    $NKE
    7/28/2025$93.00Neutral → Overweight
    Analyst
    Nike Inc.
    $NKE
    7/10/2025$76.00Buy → Hold
    DZ Bank
    Nike Inc.
    $NKE
    7/1/2025$85.00Hold → Buy
    Argus
    Nike Inc.
    $NKE
    6/27/2025$66.00 → $78.00Buy
    Needham
    Nike Inc.
    $NKE
    6/27/2025$80.00Hold → Buy
    HSBC Securities
    Nike Inc.
    $NKE
    6/18/2025$75.00 → $66.00Buy
    Needham
    Logitech International S.A.
    $LOGI
    5/7/2025Neutral → Buy
    UBS
    More analyst ratings

    $BIOS
    $LAZY
    $LOGI
    $MODV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Logitech Int'l SA upgraded by BNP Paribas Exane with a new price target

    BNP Paribas Exane upgraded Logitech Int'l SA from Neutral to Outperform and set a new price target of $109.00

    8/5/25 7:04:41 AM ET
    $LOGI
    Computer peripheral equipment
    Technology

    NIKE upgraded by Analyst with a new price target

    Analyst upgraded NIKE from Neutral to Overweight and set a new price target of $93.00

    7/28/25 8:24:12 AM ET
    $NKE
    Shoe Manufacturing
    Consumer Discretionary

    NIKE downgraded by DZ Bank with a new price target

    DZ Bank downgraded NIKE from Buy to Hold and set a new price target of $76.00

    7/10/25 8:36:12 AM ET
    $NKE
    Shoe Manufacturing
    Consumer Discretionary

    $BIOS
    $LAZY
    $LOGI
    $MODV
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Heartland Dental awards $24,000 in scholarships to Concorde Career Colleges students at 11 campuses nationwide

    Part of a growing workforce solutions partnership with Concorde, Heartland expands the program this year from 18 to 30 students KANSAS CITY, Mo., Aug. 13, 2025 /PRNewswire/ -- Concorde Career Colleges and Heartland Dental today announced the recipients of the 2025 Heartland Dental Hygiene Scholarships. Heartland is awarding a total of $24,000 in scholarships to students at Concorde campuses nationwide who demonstrate exceptional dedication, passion, and potential in the field of dental hygiene. Heartland Dental is one of the largest dental support organizations in the nation a

    8/13/25 9:15:00 AM ET
    $UTI
    Other Consumer Services
    Real Estate

    Quince Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results

    Marks major milestone with completion of enrollment in pivotal Phase 3 NEAT clinical trial evaluating lead asset, eDSP, for the treatment of A-T; topline results expected in first quarter of 2026 Closed financing priced at a premium bringing existing cash position to approximately $35 million; expected to provide runway through Phase 3 topline results and into at least second quarter of 2026 Entered into strategic relationship with Option Care Health to support commercial launch of eDSP in the U.S. Quince Therapeutics, Inc. (NASDAQ:QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases, today provided an

    8/11/25 4:05:00 PM ET
    $OPCH
    $QNCX
    Medical/Nursing Services
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)

    Imagen Dental Partners Awards Nearly $10K in Scholarships to Concorde Career Colleges' California Students

    Scholarships part of emerging workforce solutions partnership forged earlier this year SAN DIEGO, Aug. 11, 2025 /PRNewswire/ -- Concorde Career Colleges and Imagen Dental Partners today announced the three recipients of Imagen Dental Partners' $3,325 scholarships to students at Concorde's Garden Grove, San Bernardino, and San Diego campuses. This is the second round of scholarships Imagen has awarded to Concorde students and is part of a workforce solutions partnership announced earlier this year to address the demand for dental hygienists in California. Imagen Dental Partners

    8/11/25 9:15:00 AM ET
    $UTI
    Other Consumer Services
    Real Estate

    $BIOS
    $LAZY
    $LOGI
    $MODV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Devincenzi Robert Thomas bought $253,991 worth of shares (10,000 units at $25.40), increasing direct ownership by 8% to 136,765 units (SEC Form 4)

    4 - UNIVERSAL TECHNICAL INSTITUTE INC (0001261654) (Issuer)

    8/14/25 8:43:51 PM ET
    $UTI
    Other Consumer Services
    Real Estate

    Director Swan Robert Holmes bought $502,756 worth of Class B Common Stock (8,600 units at $58.46), increasing direct ownership by 37% to 31,983 units (SEC Form 4)

    4 - NIKE, Inc. (0000320187) (Issuer)

    4/7/25 4:05:03 PM ET
    $NKE
    Shoe Manufacturing
    Consumer Discretionary

    Large owner Ai Catalyst Fund, Lp bought $1,677,000 worth of shares (420,000 units at $3.99) (SEC Form 4)

    4 - ModivCare Inc (0001220754) (Issuer)

    2/3/25 9:56:40 PM ET
    $MODV
    Transportation Services
    Consumer Discretionary

    $BIOS
    $LAZY
    $LOGI
    $MODV
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by Purple Innovation Inc.

    SCHEDULE 13G - Purple Innovation, Inc. (0001643953) (Subject)

    8/14/25 8:54:30 PM ET
    $PRPL
    Home Furnishings
    Consumer Discretionary

    SEC Form 144 filed by Nike Inc.

    144 - NIKE, Inc. (0000320187) (Subject)

    8/14/25 5:35:05 PM ET
    $NKE
    Shoe Manufacturing
    Consumer Discretionary

    Amendment: SEC Form SCHEDULE 13G/A filed by Universal Technical Institute Inc

    SCHEDULE 13G/A - UNIVERSAL TECHNICAL INSTITUTE INC (0001261654) (Subject)

    8/14/25 1:31:49 PM ET
    $UTI
    Other Consumer Services
    Real Estate

    $BIOS
    $LAZY
    $LOGI
    $MODV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EXECUTIVE CHAIRMAN Parker Mark G gifted 11,295 units of Class B Common Stock and sold $6,535,903 worth of Class B Common Stock (86,078 units at $75.93), decreasing direct ownership by 12% to 744,988 units (SEC Form 4)

    4 - NIKE, Inc. (0000320187) (Issuer)

    8/18/25 4:45:59 PM ET
    $NKE
    Shoe Manufacturing
    Consumer Discretionary

    Director Devincenzi Robert Thomas bought $253,991 worth of shares (10,000 units at $25.40), increasing direct ownership by 8% to 136,765 units (SEC Form 4)

    4 - UNIVERSAL TECHNICAL INSTITUTE INC (0001261654) (Issuer)

    8/14/25 8:43:51 PM ET
    $UTI
    Other Consumer Services
    Real Estate

    EVP: CHIEF INN,PROD&DSG OFCR Mccartney Philip sold $244,138 worth of Class B Common Stock (3,162 units at $77.21), decreasing direct ownership by 8% to 35,592 units (SEC Form 4)

    4 - NIKE, Inc. (0000320187) (Issuer)

    8/14/25 4:16:27 PM ET
    $NKE
    Shoe Manufacturing
    Consumer Discretionary

    $BIOS
    $LAZY
    $LOGI
    $MODV
    Leadership Updates

    Live Leadership Updates

    View All

    Quince Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results

    Marks major milestone with completion of enrollment in pivotal Phase 3 NEAT clinical trial evaluating lead asset, eDSP, for the treatment of A-T; topline results expected in first quarter of 2026 Closed financing priced at a premium bringing existing cash position to approximately $35 million; expected to provide runway through Phase 3 topline results and into at least second quarter of 2026 Entered into strategic relationship with Option Care Health to support commercial launch of eDSP in the U.S. Quince Therapeutics, Inc. (NASDAQ:QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases, today provided an

    8/11/25 4:05:00 PM ET
    $OPCH
    $QNCX
    Medical/Nursing Services
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)

    Jørgen Vig Knudstorp Nominated to Join NIKE, Inc. Board of Directors

    NIKE, Inc. (NYSE:NKE) today announced Jørgen Vig Knudstorp has been nominated for election to its Board of Directors at the Company's 2025 annual meeting of shareholders, to be held on September 9, 2025. Mr. Knudstorp was President and Chief Executive Officer of the LEGO Group ("LEGO") from 2004 to 2016, Executive Chair of LEGO Brand Group from 2017 to 2023 and currently serves as Deputy Chair of the LEGO Foundation. He previously held various leadership positions at LEGO from 2001 to 2004. "Jørgen's strong global experience with brand and digital marketing, strategy, and consumer products, as well as his development and fostering of culture and values, will make him an excellent additi

    6/24/25 4:15:00 PM ET
    $NKE
    Shoe Manufacturing
    Consumer Discretionary

    NIKE, Inc. Appoints Michael Gonda as Executive Vice President and Chief Communications Officer

    NIKE, Inc. (NYSE:NKE) announced today that Michael Gonda will become Executive Vice President and Chief Communications Officer of NIKE, Inc., effective July 7, 2025. In this role, Gonda will lead the global communications organization, overseeing all facets of the communications strategy, including storytelling, corporate and brand reputation, issues management, and employee engagement. As a member of the company's Senior Leadership Team, Gonda will report to President and Chief Executive Officer Elliott Hill. "Michael is a deeply strategic, emotionally intelligent, purpose-driven leader who understands the power of storytelling to move both brands and people," said Hill. "His vision for

    6/2/25 1:00:00 PM ET
    $NKE
    Shoe Manufacturing
    Consumer Discretionary

    $BIOS
    $LAZY
    $LOGI
    $MODV
    Financials

    Live finance-specific insights

    View All

    NIKE, Inc. Declares $0.40 Quarterly Dividend

    NIKE, Inc. (NYSE:NKE) announced today that its Board of Directors has declared a quarterly cash dividend of $0.40 per share on the Company's outstanding Class A and Class B Common Stock payable on October 1, 2025, to shareholders of record at the close of business on September 2, 2025. About NIKE, Inc. NIKE, Inc., headquartered near Beaverton, Oregon, is the world's leading designer, marketer and distributor of authentic athletic footwear, apparel, equipment and accessories for a wide variety of sports and fitness activities. Converse, a wholly-owned NIKE, Inc. subsidiary brand, designs, markets and distributes athletic lifestyle footwear, apparel and accessories. For more information,

    8/7/25 4:15:00 PM ET
    $NKE
    Shoe Manufacturing
    Consumer Discretionary

    Universal Technical Institute Reports Fiscal Year 2025 Third Quarter Results

    Company Raises Lower End Fiscal 2025 Guidance Ranges for Revenue and New Student Starts, Expresses Increased Confidence in Long Term Plan PHOENIX, Aug. 6, 2025 /PRNewswire/ -- Universal Technical Institute, Inc. (NYSE:UTI), a leading workforce solutions provider of transportation, skilled trades and healthcare education programs, reported financial results for the fiscal 2025 third quarter ended June 30, 2025. Universal Technical Institute, Inc. operates in two reportable segments, Universal Technical Institute (UTI) and Concorde Career Colleges (Concorde), and together with its segments and subsidiaries is referred to as the "Company," "we," "us" or "our."

    8/6/25 4:05:00 PM ET
    $UTI
    Other Consumer Services
    Real Estate

    Option Care Health Announces Financial Results for the Second Quarter Ended June 30, 2025

    BANNOCKBURN, Ill., July 30, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the "Company" or "Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Financial Highlights Net revenue of $1,416.1 million, up 15.4% compared to $1,227.2 million in the second quarter of 2024Gross profit of $269.0 million, or 19.0% of net revenue, up 7.9% compared to $249.4 million, or 20.3% of net revenue, in the second quarter of 2024Net income of $50.5 million, compared to net income of $53.0 million, in the second quarter of 20

    7/30/25 7:00:00 AM ET
    $OPCH
    Medical/Nursing Services
    Health Care

    $BIOS
    $LAZY
    $LOGI
    $MODV
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by ModivCare Inc.

    SC 13D/A - ModivCare Inc (0001220754) (Subject)

    12/13/24 9:05:42 PM ET
    $MODV
    Transportation Services
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by ModivCare Inc.

    SC 13D/A - ModivCare Inc (0001220754) (Subject)

    12/13/24 5:07:48 PM ET
    $MODV
    Transportation Services
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by ModivCare Inc.

    SC 13D/A - ModivCare Inc (0001220754) (Subject)

    12/9/24 7:46:13 PM ET
    $MODV
    Transportation Services
    Consumer Discretionary